Welcome to our dedicated page for BlackRock Capital Allocation Term ord SEC filings (Ticker: BCAT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BlackRock Capital Allocation Term ord's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BlackRock Capital Allocation Term ord's regulatory disclosures and financial reporting.
Saba Capital Management, L.P., its general partner Saba Capital Management GP, LLC, and founder Boaz R. Weinstein have filed Amendment No. 19 to Schedule 13D disclosing a materially higher position in BlackRock Capital Allocation Term Trust (BCAT). As of the event date 27 June 2025, the group beneficially owns 7,802,473–7,802,474 common shares, equal to 7.45 % of BCAT’s outstanding 104,775,271 shares. The holding is entirely shared voting and dispositive power; no shares are held with sole authority.
The filing indicates that approximately $114.3 million of investor capital and margin borrowings were deployed to build the position. Items 3, 5 and 7 of the original 13D have been amended, primarily to update the source of funds and current ownership. The “Purpose of Transaction” section remains “Not Applicable,” meaning the group has not publicly outlined an activist plan at this stage. Nonetheless, Saba’s track record of pushing for tender offers, buy-backs and governance changes in closed-end funds suggests the 7.45 % stake could become influential if the position grows toward the 10 % threshold that often triggers additional disclosure and leverage.
- Reporting persons: Saba Capital Management, L.P.; Saba Capital Management GP, LLC; Boaz R. Weinstein.
- Event date: 27 Jun 2025; filing signed 30 Jun 2025.
- Shares owned: 7,802,473–7,802,474 (shared power).
- Ownership percentage: 7.45 % of BCAT common shares.
- Total cost basis disclosed: approx. $114.3 million.
FAQ
What is the current stock price of BlackRock Capital Allocation Term ord (BCAT)?
What is the market cap of BlackRock Capital Allocation Term ord (BCAT)?
